JP2022500469A5 - - Google Patents

Info

Publication number
JP2022500469A5
JP2022500469A5 JP2021515027A JP2021515027A JP2022500469A5 JP 2022500469 A5 JP2022500469 A5 JP 2022500469A5 JP 2021515027 A JP2021515027 A JP 2021515027A JP 2021515027 A JP2021515027 A JP 2021515027A JP 2022500469 A5 JP2022500469 A5 JP 2022500469A5
Authority
JP
Japan
Application number
JP2021515027A
Other languages
Japanese (ja)
Other versions
JP7429224B2 (ja
JPWO2020060916A5 (https=
JP2022500469A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/051275 external-priority patent/WO2020060916A1/en
Publication of JP2022500469A publication Critical patent/JP2022500469A/ja
Publication of JP2022500469A5 publication Critical patent/JP2022500469A5/ja
Publication of JPWO2020060916A5 publication Critical patent/JPWO2020060916A5/ja
Application granted granted Critical
Publication of JP7429224B2 publication Critical patent/JP7429224B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021515027A 2018-09-18 2019-09-16 Lpaアンタゴニストとしてのシクロヘプチル酸 Active JP7429224B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862732595P 2018-09-18 2018-09-18
US62/732,595 2018-09-18
PCT/US2019/051275 WO2020060916A1 (en) 2018-09-18 2019-09-16 Cycloheptyl acids as lpa antagonists

Publications (4)

Publication Number Publication Date
JP2022500469A JP2022500469A (ja) 2022-01-04
JP2022500469A5 true JP2022500469A5 (https=) 2023-11-08
JPWO2020060916A5 JPWO2020060916A5 (https=) 2023-11-08
JP7429224B2 JP7429224B2 (ja) 2024-02-07

Family

ID=68073224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021515027A Active JP7429224B2 (ja) 2018-09-18 2019-09-16 Lpaアンタゴニストとしてのシクロヘプチル酸

Country Status (7)

Country Link
US (1) US20220041572A1 (https=)
EP (1) EP3852747B1 (https=)
JP (1) JP7429224B2 (https=)
KR (1) KR102800284B1 (https=)
CN (1) CN112702998A (https=)
ES (1) ES2948793T3 (https=)
WO (1) WO2020060916A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102788997B1 (ko) 2018-09-18 2025-03-28 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 옥사비시클로 산
ES2946657T3 (es) * 2018-09-18 2023-07-24 Bristol Myers Squibb Co Acidos ciclopentílicos como antagonistas de LPA
AU2020384883B2 (en) 2019-11-15 2023-11-16 Gilead Sciences, Inc. Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof
TWI843503B (zh) 2020-06-03 2024-05-21 美商基利科學股份有限公司 Lpa受體拮抗劑及其用途
CN115867556B (zh) 2020-06-03 2025-05-06 吉利德科学公司 Lpa受体拮抗剂及其用途
TWI853704B (zh) 2021-05-11 2024-08-21 美商基利科學股份有限公司 Lpa受體拮抗劑及其用途
KR20240007233A (ko) * 2021-05-13 2024-01-16 길리애드 사이언시즈, 인코포레이티드 Lpa 수용체 길항제 및 이의 용도
WO2023107938A1 (en) 2021-12-08 2023-06-15 Gilead Sciences, Inc. Lpa receptor antagonists and uses thereof
AR128613A1 (es) 2022-02-25 2024-05-29 Lhotse Bio Inc Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor de lpa
CN121866249A (zh) 2023-09-08 2026-04-14 海思科医药集团股份有限公司 一种lpar1拮抗剂及其用途
WO2026061483A1 (zh) * 2024-09-19 2026-03-26 西藏海思科制药有限公司 一种lpar1拮抗剂及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062389A1 (en) 2001-02-08 2002-08-15 Ono Pharmaceutical Co., Ltd. Remedies for urinary diseases comprising lpa receptor controlling agents
US20080186971A1 (en) 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
TW201120016A (en) * 2009-12-08 2011-06-16 Abbott Lab Novel oxadiazole compounds
EP2694472B1 (en) 2011-04-05 2020-03-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
UA109868C2 (ru) 2012-06-20 2015-10-12 Ф. Хоффманн-Ля Рош Аг Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
AR108838A1 (es) 2016-06-21 2018-10-03 Bristol Myers Squibb Co Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
KR102788997B1 (ko) 2018-09-18 2025-03-28 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 옥사비시클로 산
ES2946657T3 (es) 2018-09-18 2023-07-24 Bristol Myers Squibb Co Acidos ciclopentílicos como antagonistas de LPA

Similar Documents

Publication Publication Date Title
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
JP2022500469A5 (https=)
BR112021017892A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)
BR112021015080A2 (https=)
BR112021018250A2 (https=)
BR112021017310A2 (https=)
BR112021017949A2 (https=)